Shares of Health Sciences Acquisitions Corporation (NASDAQ:HSAC) saw an uptick in trading volume on Wednesday following insider buying activity. 1,088,100 shares were traded during trading, an increase of 931% from the previous session’s volume of 105,531 shares.The stock last traded at $10.16 and had previously closed at $10.14.
Specifically, CEO Roderick Wong sold 2,000 shares of the stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $36.52, for a total transaction of $73,040.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Over the last quarter, insiders have bought 167,528 shares of company stock worth $1,712,448.
A hedge fund recently bought a new stake in Health Sciences Acquisitions stock. K2 Principal Fund L.P. bought a new stake in Health Sciences Acquisitions Corporation (NASDAQ:HSAC) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 102,926 shares of the company’s stock, valued at approximately $1,008,000.
Health Sciences Acquisitions Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the healthcare and healthcare-related industries in North America or Europe.
Recommended Story: Investing in Blue-Chip Stocks
Receive News & Ratings for Health Sciences Acquisitions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions and related companies with MarketBeat.com's FREE daily email newsletter.